*Department of Ophthalmology, Meir Medical Center, Kfar Saba
§Department of Ophthalmology, Assaf Harofeh Medical Center
†Sackler Faculty of Medicine, Tel Aviv University
‡The Ein Tal Medical Center, Tel-Aviv
∥Department of Ophthalmology, Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
Supported in part by a grant from the Clair and Amedee Martier Institute for the Study of Blindness and Visual Disorders, Tel-Aviv University.
N.G., S.O., and M.B.: Conception, design, analysis, writing. N.G., E.I.A., and M.B.: critical revision and final approval. N.G., S.O., A.B., F.S., and Y.B.: data collection. N.G., Y.B., A.K.M., and E.I.A.: materials and patient recruitment. N.G., S.O., and M.B.: literature search.
Disclosure: M. B. is actively pursuing commercial development of transscleral LTP. The remaining authors declare no conflict of interest.
Reprints: Noa Geffen, MD, Department of Ophthalmology, Meir Medical Center, Tchernihovsky 45 Street, PO Box 44100, Kfar Saba, 472130, Israel (e-mail: [email protected]).